International Journal of Chronic Obstructive Pulmonary Disease
Volume 17, 2022 - Issue
ORIGINAL RESEARCH
Clinical and Economic Impact of Long-Term Inhaled Corticosteroid Withdrawal in Patients with Chronic Obstructive Pulmonary Disease Treated with Triple Therapy in Spain
Victoria Neches García1 Market Access, GlaxoSmithKline, Madrid, SpainCorrespondence[email protected]
https://orcid.org/0000-0003-1149-5830View further author information
https://orcid.org/0000-0003-1149-5830View further author information, Laura Amanda Vallejo-Aparicio1 Market Access, GlaxoSmithKline, Madrid, Spainhttps://orcid.org/0000-0002-8579-0835View further author information
https://orcid.org/0000-0002-8579-0835View further author information, Afisi S Ismaila2 Value Evidence and Outcomes, GlaxoSmithKline, Collegeville, PA, USA;3 Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canadahttps://orcid.org/0000-0002-2876-8308View further author information
https://orcid.org/0000-0002-2876-8308View further author information, Antoni Sicras-Mainar4 Real Life Data, Atrys Health, Barcelona, Spainhttps://orcid.org/0000-0002-8232-293XView further author information
https://orcid.org/0000-0002-8232-293XView further author information, Aram Sicras-Navarro4 Real Life Data, Atrys Health, Barcelona, Spainhttps://orcid.org/0000-0002-0269-0354View further author information
https://orcid.org/0000-0002-0269-0354View further author information, , Rafael Cuervo6 Medical Affairs, GlaxoSmithKline, Madrid, Spainhttps://orcid.org/0000-0002-3522-486XView further author information
https://orcid.org/0000-0002-3522-486XView further author information, Soham Shukla2 Value Evidence and Outcomes, GlaxoSmithKline, Collegeville, PA, USAhttps://orcid.org/0000-0002-4139-0856View further author information
https://orcid.org/0000-0002-4139-0856View further author information & show all